The repression of telomerase activity during cellular differentiation promotes replicative aging and functions as a physiological barrier for tumorigenesis in long-lived mammals, including humans. However, the underlying mechanisms remain largely unclear. Here we describe how miR-615-3p represses hTERT expression. mir-615-3p is located in an intron of the HOXC5 gene, a member of the highly conserved homeobox family of transcription factors controlling embryogenesis and development. Unexpectedly, we found that HoxC5 also represses hTERT expression by disrupting the long-range interaction between hTERT promoter and its distal enhancer. The 3′UTR of hTERT and its upstream enhancer region are well conserved in long-lived primates. Both mir-615-3p and HOXC5 are activated upon differentiation, which constitute a feed-forward loop that coordinates transcriptional and post-transcriptional repression of hTERT during cellular differentiation. Deregulation of HOXC5 and mir-615-3p expression may contribute to the activation of hTERT in human cancers.
T he ends of human linear chromosome are capped by telomeres 1, 2 . Telomeres are synthesized by telomerase that consists of two core subunits, the protein subunit, hTert and the RNA subunit, hTR/hTERC 3, 4 . Although hTR/hTERC is widely expressed, hTert and consequently telomerase activity are hardly detectable in the majority of human adult somatic cells, except for some stem cells and germ cells [3] [4] [5] [6] [7] . As a result, telomeres in normal somatic cells shorten progressively during each cell division, thereby limiting cell proliferation capacity and functions as an important barrier to prevent cancer initiation 1, [8] [9] [10] .
Pluripotent stem cells express robust telomerase activity to support their continuous proliferation [11] [12] [13] . Limited telomerase expression in adult tissue stem/progenitor cells also prevents accelerated telomere shortening and supports stem cell self-renewal for tissue regeneration and repair throughout our lifespan 7, 14 . Genetic mutations in telomere-and telomeraseassociated genes can lead to various diseases, termed telomere syndromes or telomeropathies, which are characterized by accelerated telomere shortening, premature aging and increase risk for cancer 15, 16 . These findings highlight the importance of telomere homeostasis in human health.
Upon the induction of cellular differentiation, hTERT is repressed and eventually silenced in the majority of normal human somatic cells 17, 18 . The repression of hTERT expression during cellular differentiation promotes replicative aging and may be an adaptive response to an increased mutation load arising from the evolution of homeothermy in long-lived mammals 19 . In contrast, both TR and TERT are highly expressed in most somatic tissues of mice. The mechanism underlying such phenotypic divergence in regulation of TERT expression in human and mouse tissues remains unclear. Previous studies using transgenic mouse lines with bacterial artificial chromosomes have uncovered that the cis-acting regulatory elements in the hTERT genomic locus are pivotal in mediating its silencing during normal development [20] [21] [22] . However, the identity of the cis-regulatory elements and the trans-acting factors that are required to induce hTERT silencing during cellular differentiation remains unclear.
Telomerase upregulation is observed in >85% of human cancers [3] [4] [5] [6] . Recent studies have shown that mutations in hTERT promoter are the most frequent non-coding mutations in specific subsets of human cancers [23] [24] [25] [26] . These mutations not only increase hTERT mRNA expression in cancer cells, but also abolish hTERT silencing during stem cells differentiation 27 . Therefore, a failure to suppress hTERT expression during normal cellular differentiation may be hijacked by cancer cells to activate telomerase expression during cellular transformation as well.
Here we have identified roles for HoxC5 and miR-615-3p in the negative regulation of hTERT in cancer cells and during differentiation of pluripotent stem cells. We found that HOXC5 and mir-615-3p are suppressed in pluripotent stem cells, but activated specifically and robustly from the same locus during cellular differentiation. Our data suggest that HoxC5 and miR-615-3p repress hTERT via an upstream enhancer region and 3′UTR, respectively. While HoxC5 and miR-615-3p are very well-conserved between human and mouse (identity = 99.5% and 100% respectively), the TERT 3′UTR and upstream enhancer regions are conserved in long-lived mammals such as chimpanzee and macaque, but not in short-lived mammals such as mouse and rat. These results indicate that the differential regulation of TERT expression in human and mouse relies on the divergence of cis-regulatory genomic elements developed recently during the evolutionary process.
In addition, overexpression of HOXC5 and miR-615-3p in human cancer cells significantly inhibits hTERT expression and suppresses cancer cell growth both in vitro and in vivo. Analysis of RNA-Seq data set from 33 TCGA cancer types indicated that reduced HOXC5 expression contributes to the activation of hTERT in human cancers such as thymoma and testicular germ cell tumors. These results uncover a developmental-controlled regulatory circuit constitute of the HOXC5 locus that represses hTERT by targeting recently evolved genomic elements in human cells. Loss of HoxC5-mediated hTERT repression may be an alternative mechanism in the activation of hTERT expression in human cancers, especially for cancers derived from tissues, such as thymus and testis, which contain telomerase-positive progenitor cells/stem cells.
Results

Distinct regulatory functions of the hTERT 5′UTR and 3′UTR.
hTERT is upregulated in >85% of all human cancers, and higher expression of hTERT mRNA is associated with higher telomerase activity 5, 28 . Similar results were observed in a panel of pluripotent human embryonic stem (ES) cell line (WA01) and cancer cell lines with high variability (Fig. 1a, b) . We further analyzed the correlation between hTERT mRNA levels, measured by real-time RT-PCR, and telomerase activity, measured by telomeric repeat amplification protocol (TRAP), in 56 cell lines in the NCI-60 panel. Regression analysis demonstrated that telomerase activity was moderately correlated to hTERT mRNA levels (r = 0. 49) , and only about 23% (r 2 = 0.23) of the variation in telomerase activity could be explained by changes in hTERT mRNA levels ( Supplementary Fig. 1a ), suggesting the presence of other regulatory mechanisms influencing hTERT expression.
To address whether post-transcriptional regulation may play a role in the regulation of hTert expression, we cloned the hTERT 5′ UTR (58 bp) and 3′UTR (560 bp) individually or together at the respective ends of the Renilla luciferase reporter gene (hRluc) in psiCHECK2 ( Supplementary Fig. 1b) . The psiCHECK2 vector also contains a constitutively expressed Firefly luciferase gene (hFLuc + ), which is used for normalization ( Supplementary  Fig. 1b) . We found that different cancer cell lines and also WA01 human ES cells transfected with psiCHECK2-5′UTR all displayed lower normalized Renilla luciferase activity than those transfected with the control plasmid, psiCHECK2 (Fig. 1c) . In contrast, the effects of the hTERT 3′UTR on Renilla luciferase activity were variable and cell line-dependent (Fig. 1d) . Similar cell-linespecific results were observed when the cells were transfected with psiCHECK2-5′ + 3′UTR (Fig. 1e) . Interestingly, cells with relatively lower telomerase activity generally also displayed relatively lower levels of Renilla luciferase activity upon transfection with psiCHECK2-3′UTR or psiCHECK2-5′ + 3′ UTR, and vice versa (compare Fig. 1b, d , e). These results suggest that the hTERT 3′UTR plays a role in regulating the differential expression of hTert in different cell lines.
miR-615-3p is a novel negative regulator of hTERT expression. MicroRNAs often regulate gene expression via 3′UTRs 29 . To investigate whether miRNAs are involved in the regulation of hTERT, we engineered HeLa reporter cells stably integrated with psiCHECK2-5′ + 3′UTR (hTERT) and performed a screen using the Dharmacon miRIDIAN ® miRNA hairpin inhibitor library, which targets 757 mature miRNAs (miRBase release 10.0, Supplementary Fig. 2a ). We performed three independent screens and plotted the Z score distribution of the log 2 ratio for Renilla/Firefly luciferase activity (Fig. 1f) . We identified eight miRNA inhibitors with a Z score >2.7 in multiple screens (p value = 0.0034, one-sided test), and verified that they increased the Renilla/Firefly luciferase activity ratio in psiCHECK2-5′ + 3′ UTR (hTERT) reporter cells (Fig. 1g) . In addition, two of the miRNA hairpin inhibitors, targeting miR-483-3p and miR-615-3p, also dramatically increased endogenous hTERT mRNA levels and telomerase activity in HeLa cells (Fig. 1h, i) . Neither of these miRNAs has been previously shown to regulate the expression of hTert. Interestingly, previous studies revealed that miR-615-3p level is low in pluripotent stem cells and increases dramatically upon differentiation 30, 31 , which is directly opposite to hTert expression in differentiated cells.
We compared the hTERT 3′UTR from different species 32 and found that it is highly conserved specifically in long-lived primates ( Supplementary Fig. 2b ), suggesting that the role of the hTERT 3′UTR in regulating hTERT expression was acquired late in genomic evolution. We used miRWalk 2.0 33 to identify potential miR-615-3p target site in the hTERT 3′UTR (Fig. 2a) . We then mutated the predicted seed region (M1) as well as both seed region and an additional conserved site (M2) in the psiCHECK2-5′ + 3′UTR (hTERT) reporter construct (Fig. 2b) . HeLa and RKO cells expressing psiCHECK2-5′ + 3′UTR-M1 (hTERT) displayed a~30% increase in the Renilla/Firefly luciferase luminescence ratio compared to those expressing psiCHECK2-5′ + 3′UTR (hTERT) (Fig. 2c) . Elimination of both the miRNA binding seed sequence and the additional conserved site (psiCHECK2-5′ + 3′UTR-M2) further increased the Renilla/ Firefly luciferase luminescence ratio (Fig. 2c) . Consistent with these results, overexpression of miR-615-3p further decreased Renilla/Firefly luciferase luminescence ratio in HeLa cells transfected with psiCHECK2-5′ + 3′UTR, but not psiCHECK2-5′ + 3′UTR-M2 ( Supplementary Fig. 3a) . These results suggest that miR-615-3p negatively regulates hTERT by targeting this region within the 3′UTR.
To further investigate the function of miR615-3p in regulating endogenous hTERT expression, we compared the expression profile of hTERT mRNA and miR-615-3p in NCI-60 cell lines. We found that HOP-92 and RXF393 cells displayed high levels of miR-615-3p but low levels of hTERT mRNA ( Supplementary  Fig. 3b ). Further, transient transfection of the miR-615-3p hairpin inhibitor into these two cell lines led to a significant increase in hTERT mRNA expression and a corresponding increase in telomerase activity (Fig. 2d, e) . In contrast, RPMI-8226, IGR-OV1 and HCC-2998 cells have low levels of miR-615-3p and high levels of hTERT mRNA ( Supplementary Fig. 3b ). We observed a significant reduction of hTERT mRNA levels and telomerase activity when miR-615-3p was overexpressed in these cell lines (Fig. 2f, g ). Thus, miR-615-3p represses endogenous hTERT expression in various cancer cell lines.
To further confirm the function of miR-615-3p in the regulation of hTERT expression, we utilized the CRISPR/ Cas9 system to introduce small deletion in the region of the mir-615 hairpin that is crucial for its maturation. We isolated two clonal-derived RKO cell lines using two independent sgRNAs, RKO-KO-1 and RKO-KO-2 ( Supplementary Fig. 4 ). As expected, RKO-KO-1 and RKO-KO-2 displayed loss of miR-615-3p expression (Fig. 2h) , and increased hTERT mRNA levels and telomerase activity (Figs. 2i, j) , relative to parental RKO cells. We also observed an increase in telomere length in RKO-KO-1 and RKO-KO-2 compared to parental RKO cells (Fig. 2k) . We further utilized the CRISPR/Cas9 system to introduce small deletions or mutations into the endogenous hTERT 3′UTR. As shown in Supplementary Fig. 5a and 5b, clonal-derived RKO cells harboring biallelic deletions or mutations in the miR-615-3p-binding site displayed increased hTERT mRNA levels, but not in the cells harboring deletions outside the miR-615-3p-binding site. Taken together, these data suggest that miR-615-3p suppresses endogenous hTERT expression by targeting the 3′UTR of hTERT.
HoxC5 inhibits the expression of hTERT in cancer cells. The mir-615 is located within intron 1 of the HOXC5 gene (Fig. 3a) , and the transcription of HOXC5 is accompanied by the expression of miR-615 34 . Because HOX genes are important not only in development, but are also aberrantly expressed in many human malignancies 35 , we investigated whether HoxC5 itself might influence the expression of hTERT. Indeed, we found that lentivirus-mediated overexpression of HoxC5, but not GFP, resulted in significantly reduced hTERT mRNA levels, reduced telomerase activity, and gradual telomere shortening in multiple cancer cell lines, including HeLa, PC-3, U-251 and BT549 cells ( Fig. 3b-d) . In contrast, we found that knockdown of the endogenous HOXC5 gene in HeLa cells, using two independent lentiviral-expressed anti-HOXC5 shRNAs, resulted in reduced HOXC5 mRNA levels (Fig. 3e) , increased hTERT mRNA levels (Fig. 3f) , and telomere elongation (Fig. 3g) . Inactivation of miR-615 expression does not affect the expression of endogenous HOXC5 ( Supplementary Fig. 5c, d ). Together, our data suggest that miR-615-3p and HoxC5 form a feed-forward loop to negatively regulate hTERT mRNA expression, telomerase activity and telomere elongation.
Activation of mir-615-3p and HOXC5 upon differentiation. Hox proteins transcriptionally regulate key target genes that are required for vital developmental processes 36, 37 . Previous studies have shown that Hox proteins form complexes with Pbx and/or Meis -TALE (Three Amino acid Loop Extension) superfamily homeodomain proteins to acquire DNA-binding specificity 38, 39 . There are four Pbx proteins and three Meis proteins expressed in humans. We investigated the expression patterns of hTERT, mir-615-3p, HOXC5, PBX1-4 and MEIS1-3 during the differentiation (Fig. 4a ) of human ES cells WA01 and WA18 into neural progenitor cells in vitro 40, 41 . As expected, the differentiation of ES cells into neural progenitors triggered rapid downregulation of OCT-4 and NANOG, rapid induction of the neural progenitor marker PAX6 ( Fig. 4b and Supplementary Fig. 6a ), and also the gradual downregulation of hTERT expression ( Fig. 4c and Supplementary Fig. 6b ). Importantly, we observed a dramatic increase in both miR-615-3p ( Fig. 4d and Supplementary Fig. 6c ) and HOXC5 mRNA levels ( Fig. 4e and Supplementary Fig. 6d ), which plateaued around P2-P4. While the expression of MEIS1 and MEIS2 is also dramatically upregulated upon neural induction of ES cells, we only observed moderate increases in PBX4 and MEIS3 expression, and little changes in PBX1, 2, and 3 expression ( Fig. 4f and Supplementary Fig. 6e ). These results indicate that mir-615-3p, HOXC5, PBX4, MEIS1, and MEIS2 are dramatically upregulated upon differentiation of human ES cells into neural progenitors.
The HoxC5 homeodomain is required to repress hTERT. Previous studies have shown that the homeodomain (HD) and hexapeptide (HX) motifs within Hox proteins are important for their function 42, 43 . The HX motif contains a short peptide, YPWM, which is important for Hox protein interactions with TALE superfamily homeodomain proteins in vitro, whereas the homeodomain (HD) is necessary for DNA binding 44 . To investigate whether these motifs are required for HoxC5-mediated repression of hTERT, we engineered HoxC5 mutants with disruptions of either the HX or HD motifs (Fig. 5a ). We found that mutation of the HD domain, but not the HX domain, abrogated HoxC5-mediated repression of hTERT and telomerase activity in both HeLa cells (Fig. 5b, c ) and PC-3 cells ( Supplementary Fig. 7a , 7b). The mutations in the HX or HD motifs did not affect the expression of HoxC5 in HeLa ( Fig. 5d ) and PC-3 cells ( Supplementary Fig. 7c ). Thus, the DNA-binding activity of HoxC5 HD is required to repress hTERT expression.
HoxC5 recruits Pbx4 and Meis3 to repress hTERT. Hox proteins form complexes with Pbx and/or Meis -TALE (Three Amino acid Loop Extension) superfamily homeodomain proteins to acquire DNA-binding specificity 38, 39 . To identify HoxC5-binding partners that are necessary for the repression of hTERT, we investigated which Pbx and Meis proteins can interact with HoxC5 in cancer cells.
We found that immunoprecipitation of V5-tagged HoxC5 resulted in specific co-immunoprecipitation of Flag-tagged Pbx4, but not of Pbx1, 2, and 3 ( Fig. 5e ). Consistent with these results, immunoprecipitation of Flag-tagged Pbx4, but not of Flag-tagged Pbx1, 2 or 3, resulted in efficient co-immunoprecipitation of V5-tagged HoxC5 ( Supplementary Fig. 7d ). Further, we performed an in vitro binding assay and found that recombinant 6xHis-tagged HoxC5 can efficiently pull down in vitro translated and 35 S-Methionine labeled Pbx4, but not Pbx1, 2 or 3 ( Fig. 5f ). Significance was determined by t test. *P < 0.05. PD population doubling
Next we probed the interaction of HoxC5 and Meis proteins. We found that immunoprecipitation of Flag-tagged HoxC5 resulted in specific co-immunoprecipitation of V5-tagged Meis3, but not Meis1 and 2 (Fig. 5g) . Consistent with these data, immunoprecipitation of V5-tagged Meis3, but not V5-tagged Meis1 and 2, resulted in efficient co-immunoprecipitation of Flag-tagged HoxC5 (Supplementary Fig. 7e ).
Taken together, our results suggest that Pbx4 and Meis3 interact specifically with HoxC5. To investigate whether Pbx4 and Meis3 can synergize with HoxC5 to mediate the repression of hTERT, we transiently expressed GFP (control), HoxC5, Pbx4 and Meis3, alone or in combination, in HeLa cells and evaluated hTERT mRNA levels after 24 h. We found that transient overexpression of HOXC5, but not GFP, resulted in a reduction in hTERT mRNA levels (Fig. 5h) . Although transient overexpression of PBX4 and MEIS3 alone did not significantly reduce hTERT mRNA levels, transient overexpression of PBX4 or MEIS3 in combination with HOXC5 led to a synergistic reduction in hTERT mRNA levels (Fig. 5h) . These results suggest that HoxC5 expression in HeLa cells is limiting, and the repression of hTERT by HoxC5 is enhanced by Pbx4 and Meis3.
A HoxC5-Pbx4 complex recruits Class I HDACs. Hox proteins can act as transcription activators or repressors in specific cellular contexts, depending on the recruitment of co-regulators. Hox-Pbx complexes have been shown to recruit HDACs for transcriptional repression 45 . In addition, the pan-HDAC inhibitor-Trichostatin A (TSA) can induce the expression of hTERT, suggesting that HDACs repress hTERT expression in certain cells 46, 47 . To pinpoint which class of HDACs is necessary to repress hTERTin vitro, we treated PC-3 cells with inhibitors of class I HDACs (MS-275) or class II HDACs (MC1568). Similar to TSA treatment, hTERT expression was activated by the inhibition of class I HDACs, but not of class II HDACs ( Supplementary  Fig. 8a ).
To probe the interaction of HoxC5 and Pbx4 with class I HDACs, we transiently co-expressed V5-tagged HOXC5 or V5-tagged PBX4 with Flag-tagged HDAC1, HDAC2 or HDAC3 in HeLa cells ( Supplementary Fig. 8b-d) . We found that immunoprecipitation of V5-tagged HoxC5 resulted in coimmunoprecipitation of Flag-tagged HDAC3, but not HDAC1 and HDAC2 (Supplementary Fig. 8b ). Slightly different from the results obtained with V5-tagged HoxC5, immunoprecipitation of V5-tagged PBX4 resulted in efficient co-immunoprecipitation of both HDAC1 and HDAC3, but not HDAC2 ( Supplementary  Fig. 8c and 8d) . Together, these results suggest that a HoxC5:Pbx4 complex recruits HDAC1 and/or HDAC3 for repression of hTERT.
HoxC5 represses hTERT by binding to upstream enhancer region. We hypothesized that HoxC5 represses hTERT by binding to promoter-distal regulatory elements. However, the consensus binding motif for human HoxC5 is not known. Therefore, we profiled genome-wide HoxC5-binding sites by ChIP-Seq in PC-3 cells. We found that both endogenous HoxC5 and overexpressed Flag-tagged HoxC5 bind to a site −20 kb upstream of the hTERT transcriptional start site (TSS) in PC-3 cells (Fig. 6a) . Consistent with the observed interaction between HoxC5 and Pbx4 (Fig. 5e) , ChIP-Seq showed that overexpressed Flag-tagged Pbx4 also bound to the site −20 kb upstream of the hTERT TSS in PC-3 cells. This region is marked by H3K27ac and H3K4me1 in human ES cells and PC-3 cells, indicative of an active enhancer region, which is consistent with permissive expression of hTERT in these cell types. In contrast, IMR90 cells show depletion of H3K27ac at this region, and enrichment of H3K27me3 spanning the hTERT genomic locus, consistent with the silencing of hTERT in primary fibroblasts. We used MEME to identify potential HoxC5-binding motifs within the HoxC5 ChIP-Seq peaks from endogenous HoxC5 in PC-3 cells 48 , and uncovered a putative DNA-binding consensus ( Supplementary Fig. 9a) . A similar motif can be identified within the hTERT upstream enhancer region bound by HoxC5 (Supplementary Fig. 9b) .
Next, we analyzed available 4C-seq data in A375 and BLM cells 49 (Fig. 6a) . In addition, overexpression of HoxC5 in PC-3 and A375 cells resulted in a corresponding depletion of RNA Pol II as well as histone marks associated with active gene transcription such as H3K4me1 and H3K27ac (Fig. 6b, c) at hTERT promoter and −20 kb enhancer, but not the −10 kb region. Similar results were observed upon neural differentiation of WA01 human ES cells (Fig. 6d) .
To further address the importance of this upstream enhancer in the regulation of hTERT expression, we designed four specific Fig. 9b ). Targeting of dCas9-KRAB fusion protein using these sgRNAs, but not control sgRNAs, to the hTERT upstream enhancer region also resulted in the suppression of hTERT expression in A375 cells (Fig. 6e) as well as depletion of RNA Pol II, H3K4me1 and H3K27ac at hTERT promoter and enhancer, but not at hTERT −10 kb region ( Supplementary Fig. 9c ). The depletion of RNA Pol II, H3K4me1, and H3K27ac from hTERT promoter is likely due to the disruption of long-range interaction between hTERT promoter and the upstream enhancer by HoxC5, leading to the suppression of hTERT expression. As shown in Supplementary Fig. 10 , overexpression of HOXC5, but not GFP, resulted in reduced interaction between hTERT promoter and its upstream enhancer specifically.
We further analyzed the sequence of this putative hTERT upstream enhancer region in different species and found that it is highly conserved in long-lived primates ( Supplementary Fig. 11 ). Interestingly, we also found that human and mouse HoxC5 share extremely high identity (Supplementary Fig. 12a ). In addition, overexpression of mouse HOXC5 also resulted in suppression of hTERT expression in HeLa cells (Supplementary Fig. 12b ), providing the possibility that mouse HoxC5 can mediate the silencing of hTERT by targeting the same region. In contrast, overexpression of miR-615-3p or mHOXC5 does not affect the expression endogenous mTERT in three different mouse cell lines ( Supplementary Fig. 12c -n).
HOXC5 and miR-615-3p inhibit cancer cell growth. We further analyzed genome-wide endogenous HoxC5-binding sites using Genomic Regions Enrichment of Annotations Tool (GREAT) and uncovered an over-representation of GO terms pertaining to cellular differentiation, including the TGF-β pathway 50, 51 ( Fig. 6f) . Activation of genes in the TGF-β signaling cascade was confirmed by real-time RT-PCR in PC-3 cells overexpressing HOXC5 and upon neural induction of normal human ES cells (Supplementary Fig. 13 ). In addition, telomerase is often aberrantly activated in cancer, and inhibition of hTERT expression suppresses cancer cell proliferation 52 . To study the potential role of miR-615-3p and HoxC5 in cancer cell proliferation, we transduced PC-3 cells with lentivirus expressing GFP, HOXC5, or mir-615-3p alone, or HOXC5 and mir-615-3p in combination. As expected, we observed an increase in miR-615-3p levels in PC-3 cells transduced with lentivirus expressing mir-615-3p alone or co-expressing HOXC5 and mir-615-3p ( Supplementary Fig. 14a ), as well as increased HoxC5 levels in PC-3 cells transduced with lentivirus expressing HOXC5 alone or co-expressing HOXC5 and mir-615-3p (Supplementary Fig. 14b ). Consistent with our previous results, real-time RT-PCR revealed that overexpression of mir-615-3p alone moderately reduced hTERT mRNA levels, overexpression of HOXC5 alone resulted in >50% reduction in hTERT mRNA levels, and co-expression of HOXC5 and mir-615-3p resulted in further repression of hTERT mRNA levels ( Supplementary Fig. 14c ).
We found that overexpression of mir-615-3p alone did not significantly affect the colony forming ability of PC-3 in vitro, although the colony size was smaller in PC-3 cells overexpressing mir-615-3p as compared to parental PC-3 cells (Fig. 7a, b) . In contrast, overexpression of HOXC5 significantly suppressed the ability of PC-3 cells to form colonies in vitro, and co-expression of HoxC5 and miR-615-3p further reduced the size of colonies without significantly affecting their number. Consistent with these results, overexpression of HOXC5 in PC-3, BT549 and HeLa cells inhibited cancer cell proliferation in vitro ( Supplementary  Fig. 14d-f) .
We established xenograft models to further validate the effects of miR-615-3p and HoxC5 on cancer cell growth in vivo. We injected PC-3 cells expressing GFP, HOXC5, or mir-615-3p alone, or co-expressing HOXC5 and mir-615-3p, subcutaneously into immunocompromised NSG mice and followed the tumor growth for 5 weeks (Fig. 7c) . At 5 weeks post-injection, tumors derived from PC-3 cells overexpressing HOXC5 alone or in combination with mir-615-3p were significantly smaller than those overexpressing GFP alone (Figs. 7c, d, e) . Overexpression of HOXC5 in PC-3 also resulted in rapid telomere shortening (Fig. 3d) and induction of telomere-dysfunction induced foci (TIFs) (Supplementary Fig. 15 ), which may contribute to the inhibition of cancer cell proliferation.
Deregulation of HOXC5 expression in human cancers.
Telomerase upregulation is observed in >85% of all human cancers [3] [4] [5] [6] [7] . Although hTERT promoter mutations and genomic rearrangements have been shown to activate telomerase expression in a subset of human cancers [23] [24] [25] [26] 53 , alternative mechanisms remain to be explored to understand the activation of telomerase in a vast majority of human cancers without known hTERT promoter mutations or genomic rearrangements. On the other hand, telomerase is highly expressed in several human adult tissues, such as thymus, testis and bone marrow [3] [4] [5] [6] [7] . Failure to suppress the expression of hTERT during cellular differentiation in these tissues due to genetic alterations may be hijacked by cancer cells to activate telomerase.
On the basis of the expression data from the HUMAN PROTEIN ATLAS, the expression of HOXC5 can be detected in multiple human tissues (Supplementary Fig. 16 ). Next, we wanted to examine the correlation of hTERT and HOXC5 expression in human cancers. We examined the expression of hTERT and HOXC5 mRNA using RNA-Seq data in 33 cancer types from the TCGA consortium. As shown in Supplementary Fig. 17 , the expression of hTERT and HOXC5 in different human cancers has been wide spread. We observed significant correlation (Spearman's correlation, P < 0.05) in~40% (n = 13/33) of the cancer types between HOXC5 and hTERT expression. However, only thymoma (THYM, Spearman r = −0.23, p = 0.02, Fig. 7f,) and testicular germ cell tumor (TGCT, Spearman r = −0.32, p < 0.001, Fig. 7i ), which originated from telomerase-rich tissues, showed strongest inverse correlation between HOXC5 and hTERT expression. Interestingly, upon examining the expression pattern of hTERT and HOXC5 across all 33 cancer types, THYM and TGCT have the highest median expression of hTERT (8.23 RSEM log2 units for THYM and 5.58 RSEM log2 units for TGCT) and a concordantly low expression of HOXC5 (2.19 RSEM log2 units for THYM and 2.49 RSEM log2 units for TCGT). These results indicate the possibility that the reduced HOXC5 expression may contribute to the activation of hTERT in cancers such as TGCT and THYM that rarely harbor hTERT promoter mutations 54, 55 .
Consistent with the observation that the expression of HOXC5 and miR-615 is co-regulated 34 , we also observed strong positive correlation between the expression of HOXC5 and miR-615-3p (Fig. 7h-k) in THYM and TGCT. However, we did not observe significant negative correlation between the expression of miR-615-3p and hTERT (Fig. 7g-j) . These results suggest that miR-615-3p only plays a fine-tuning role 56, 57 in modulation of hTERT expression, while HoxC5 plays the key role in hTERT suppression.
Discussion
Telomerase-directed telomere maintenance is essential during embryogenesis and development. In adult humans, telomerase activity is only detectable in germ cells and some stem cells, and is absent in the majority of normal somatic cells. The repression of telomerase in adult somatic cells limits their cell proliferation capacity and functions as a barrier to prevent tumorigenesis. However, the molecular mechanisms underlying the repression and eventual silencing of hTERT expression remain largely unknown. Here we show that the induction of HOXC5 and miR-615-3p during stem cell differentiation represses hTERT via transcriptional and post-transcriptional pathways, respectively. These results are consistent with previous studies showing that cis-acting elements in the hTERT locus are necessary in mediating its silencing during normal development in transgenic mice 20, 21 .
In this study, we have shown that the hTERT 3′UTR plays an important role in the regulation of hTERT expression. Previous attempts to identify miRNAs that regulate hTERT expression have been limited by miRNA target-predicting programs 58 . Our unbiased genome-wide screen identified several miRNA candidates that target the 3′UTR of hTERT. Our data indicated that miR-615-3p negatively regulates hTERT expression by targeting hTERT 3′UTR. The expression of mir-615-3p likely functions as a micro-switch to further repress the expression of hTERT. Such a micro-switch likely sets a threshold for the expression of hTert protein until the hTERT mRNA reaches a significant level, thus preventing the leaky expression of genes such as hTert, after cellular differentiation 56, 57 . Other potential targets of miR-615-3p were predicted using the microT-CDS algorithm (Supplementary Table 1 ). None of the potential targets seems to play a role in the regulation of hTERT expression directly.
The mir-615 locus is located within the first intron of HOXC5, and it has a restricted phylogenetic distribution that arises in the ancestor of placental mammals. Interestingly, we found that HoxC5 also represses telomerase expression. Our data suggest that HoxC5 binds to an unanticipated upstream enhancer region of hTERT, therefore disrupting the long-range interaction between hTERT promoter and its upstream enhancer to repress hTERT expression.
Both miR-615-3p and Hox family proteins are well-conserved in mammals: human and mouse miR-615-3p have identical mature sequence and the identity between human and mouse HoxC5 is 99.5% (Supplementary Fig. 12a ). Our results indicate that the 3′UTR and upstream enhancer region of hTERT are highly conserved in long-lived primates, but not in short-lived mammals ( Supplementary Fig. 2b and Supplementary Fig. 11 ).
These results highlight that the divergence of cis-regulatory elements (TERT 3′UTR and upstream enhancer) developed during the recent evolutionary processes plays essential role in differential regulation of TERT expression in human and mouse. Consistent with this hypothesis, overexpression of mouse HoxC5 is able to suppress hTERT expression in HeLa cells ( Supplementary Fig. 12b ), while overexpression of miR-615-3p or mouse HOXC5 in mouse cells does not affect the expression of mTERT ( Supplementary Fig. 12c-n) . It was shown previously that a 160-kb transgenic bacterial artificial chromosome (BAC) spanning the hTERT locus maintains its human species-specific silencing throughout mouse development [20] [21] [22] . This BAC contains the 3′UTR and upstream enhancer regions that we identified, and we propose that mouse miR-615-3p and HoxC5 repress hTERT via these elements.
Deregulation of HOX and TALE genes have been implicated in many human diseases, including cancer 35 . For example, strong expression of HOXC5 can be detected in cells representing mature stages of lymphoid cell differentiation, while HOXC5 expression could not be detected in leukemic cells (with activated hTERT expression) representing immature stages of lymphoid differentiation 59 .
Our results indicate that both miR-615-3p and HoxC5, expressed from the same locus, repress hTERT expression during stem cell differentiation. Further, overexpression of miR-615-3p and HoxC5 suppress cancer cell growth both in vitro and in vivo in mouse xenograft model. Analysis of RNA-Seq data set from 33 TCGA cancer types suggests that reduced HOXC5 expression contributes to the activation of hTERT in human cancers such as thymoma and testicular germ cell tumors. These results also suggested that the loss of hTERT repression by HoxC5 may be an alternative mechanism in activating hTERT expression in human cancers, especially for cancers (such as TGCT and THYM) derived from tissues with high telomerase activity. These results provide a novel mechanism for the activation of telomerase in human cancers in addition to known hTERT promoter mutations and translocations. Consistent with this hypothesis, hTERT promoter mutations are rarely identified in TGCT and THYM 54, 55 .
Thus, our study links the evolutionarily conserved Hox and TALE proteins to hTERT expression, which are all tightly coordinated with cellular differentiation and reprogramming. Understanding how miR-615-3p and HoxC5 mediate the cellspecific repression of hTERT and its implication in telomerase activation in human cancers can provide new avenues and targets for anti-cancer therapy.
Methods
Cell culture. NCI-60 cell lines (ATCC) were cultured in RPMI medium with 10% fetal bovine serum and penicillin/streptomycin. Only 56 cell lines were used in this study, excluding MCF7ADRr, MDA-MB-435, MDN and OVCAR4. In addition, HEK293, HEK293T, HepG2, HeLa, and RKO cells were cultured in DMEM high glucose medium with 10% fetal bovine serum and penicillin/streptomycin. Feederindependent human WA01 and WA18 embryonic stem cells from WiCell were grown on matrigel (BD Biosciences)-coated cell culture dishes using mTeSR1 culture medium (Stemcell Technologies) 41 . When the cells reached 80-90% confluence, they were passaged using Dispase (Stemcell Technologies), and split 1:6-1:12 onto new matrigel-coated cell culture dishes. No mycoplasma contamination was detected in cell lines used in this study.
Molecular cloning. The 5′-(58 bp) and 3′-(560 bp) UTRs of hTERT are cloned individually or together at the 5′ or 3′ ends of Renilla luciferase reporter gene (hRluc). The precursors of hsa-miR-615-3p plus upstream and downstream flanking sequences (total approximating 600 base pairs) were amplified from human genomic DNA isolated from WA01 cells. Flag-HOXC5, HOXC5 M1, HOXC5 M2, PBX1, PBX2, PBX3, PBX4, and V5-HOXC5, MEIS1, MEIS2, MEIS3, and GFP-miR-615-3p were constructed using pHR'CMVGFPIRESHygroWSin18 and HR'CMVGFPIRESPuro3WSin18 based lentivector 60 .
Antibodies and reagents. Lipofectamine2000 (Thermo Scientific); goat anti-rabbit and sheep anti-mouse secondary antibodies conjugated to horseradish peroxidase (Jackson ImmunoResearch); antibodies for V5 (Thermo Scientific, #E10/V4RR), V5-HRP (Thermo Scientific, #R961-25), Flag (Sigma-Aldrich, #F1804), Flag (M2)-HRP (Sigma-Aldrich, #A8592), HOXC5 (Sigma-Aldrich, #HPA026794), PBX4 (Sigma-Aldrich, #HPA049859), PolII (Millipore, #05-623), Rabbit IgG (Millipore, #PP64B), H3K4Me1 (Abcam, #ab8895), H3K27ac (Abcam, #ab4729), Actin (Santa Cruz Biotechnology, #I-19); GAPDH (Cell Signaling, #2118) were used. EDTA-free complete protease inhibitor cocktail (Roche, #05056489001), Pan-HDAC inhibitor Trichostatin A (Sigma-Aldrich, #T1952), HDAC class I inhibitor MS-275 (SigmaAldrich, #EPS002), HDAC class II inhibitor MC1568 (Sigma-Aldrich, #M1824) were dissolved in dimethyl sulphoxide (DMSO).
Generation of HeLa reporter cell line. To engineer HeLa psiCHECK2-5'+3'UTR (hTERT) reporter cell line, the 5′-(58 bp) and 3′-(560 bp) UTRs of hTERT were cloned together at the 5′ and 3′ ends of Renilla luciferase reporter gene (hRluc) in psiCHECK2 vector using the available restriction enzyme sites. The puromycin drug selection marker was inserted in the Nhe I restriction enzyme site in psiCHECK2 plasmid. The plasmid was transfected into HeLa cells using lipofatemin2000. The cells were maintained in DMEM high glucose medium with 10% fetal bovine serum and penicillin/streptomycin with 0.5 μg/ml puromycin for two weeks, puromycin-resistant colonies were isolated and screened for Renilla and Firefly luciferase activity.
Luciferase reporter assay. For luciferase assay, 10,000 HeLa cells were seeded in 24-well plates. About 24 hr after seeding, cells were transiently transfected with 100 ng psiCHECK2, psiCHECK2-3′UTR, psiCHECK2-5′UTR, psiCHECK2-5′ + 3′UTR (TERT) or psiCHECK2-3′UTR mutants using Lipofectamine 2000. About 16-24 hr after the transfection, cells were lysed in 1x Glo Lysis buffer (Promega) and luciferase activity was measured with the luciferase assay reagent (Promega) according to manufacturer's instructions. Luciferase activities were determined using a multimode microplate reader (Infinite 200 PRO,Tecan). Three independent experiments were performed for each group.
Genome-wide screen to identify miRNAs that target hTERT. For the genomewide screen, the miRNA inhibitor library targeting 757 human miRNA inhibitors was printed on four 384-well plates (Grenier) with negative controls (miRNA inhibitor control) and positive controls (Firefly Luciferase siRNA and Renilla luciferase siRNA) in the designated wells. Plates were printed with miRNA inhibiter (2.5 µl of 500 nM miRNA inhibiter per well) and frozen at -30°C before use. For reverse transfection, a master mix of 0.02 µl of lipofectamine2000 and 4.98 µl of Opti-MEM (Invitrogen) was added to each well of the miRNA inhibitor plates and incubated for 20 min. Subsequently, 3000 HeLa reporter cells in DMEM medium were seeded in each well. Reagents and cells were dispensed onto the plate using a multidrop combi reagent dispenser (Thermo Scientific). Three days post transfection, Dual-Glo luciferase assay reagents (Promega) were used to measure the Firefly luciferase and Renilla luciferase activity according to the manufacturer's instructions. The ratio of Renilla/Firefly luminescence for each well was calculated.
RNA isolation and quantitative RT-PCR. For quantification of HOXC5, hTERT, PBX1-4 and MEIS1-3 mRNA expression, total RNAs were isolated using NucleoSpin RNA kit (Macherey-Nagel). About 300 ng of RNA from each sample was used for real-time RT-PCR using KAPA SYBR FAST Bio-Rad iCycler (Kapa Biosystems) and CFX96 Touch Real-Time PCR Detection System (Bio-Rad). GAPDH was used as internal control for normalization. For quantification of hTERT expression, the Taqman probe against TERT (Hs00972656_m1 FAM, Applied Biosystems) and GAPDH (Hs02758991_g1 FAM, Applied Biosystems) were used for real-time RT-PCR. For quantification of miR-615-3p expression, total RNAs were isolated using Trizol (Thermo Scientific). Reverse transcription of miR-615-3p and RNU6B (for normalization) was conducted using the TaqMan® MicroRNA reverse transcription kit (Thermo Scientific) followed by PCR using TaqMan® Fast Universal PCR Master Mix (2×), according to the manufacturer's instructions. U6 small nuclear RNAs were used as an internal control for normalization.
Real-time TRAP assay. Real-time TRAP assay was performed as previously described 61 . Briefly, the samples were spin down at 17,100 xg RCF for 20 min at 4°C in a microcentrifuge. TRAP reaction was carried out in 1× TRAP buffer (20 mM Tris-HCl pH8.3, 1.5 mM MgCl 2 , 63 mM KCl, 0.05% Tween 20 (Roche), 1 mM EGTA, 0.1 mg/ml BSA), 50 μM dNTPs, and 8 ng/μl TS Primer (5′-AATCCGTC-GAGCAGAGTT-3′) in a 10-μl total volume for 30 min at 30°C, and the reaction was stopped by heating at 94°C for 1 min. The PCR reaction mixture contained 1X TRAP buffer, 4 ng/μl ACX primer 5′-GCGCGGCTTA CCCTTACCCTTACCC-TAACC-3′, 15% glycerol, 1:2000 SYBR Green from Invitrogen, 0.08 U/μl Taq polymerase and was initiated at 94°C for 2 min, followed by 45 cycles of 95°C for 5 s, 50°C for 6 s, and 72°C for 10 s. The threshold cycle values (Ct) were determined from semi log amplification plots. All samples were run in triplicates.
Genomic DNA extraction and Southern blotting. Genomic DNA was extracted using Gentra Puregene Genomic DNA Purification Kit (Qiagen). For telomere length measurement, the genomic DNA was digested with HphI and MnlI at 37°C for 16 hr. The DNA blot was hybridized with 32 P-labeled (TTAGGG) 6 oligonucleotides as previously described 41, 62 .
CRISPR. The miR-615-3p hairpin region was subjected to potential sgRNA target search using the online software created by Feng Zhang's group (http://crispr.mit.edu). The very top hits (sgRNA#1: 5′-CTTATTGTTCGGTCCGAGCCTGG-3′ and sgRNA#2: 5′-CACCCTCGAGATCCGAGCACCGG=3′) were chosen and used for the experiments hence described 63 . The isolation of single cell-derived clones with insertion and deletion is described previously 64 . CRISPR sgRNA used for engineer of hTERT 3′UTR truncation and knockin mutants is 5′-TGCCGTCTTCACTTCCC-CACAGG-3′. The single-stranded oligo (5′-CGGCTGAAGGCTGAGTGTCCGGCT-GAGGCCTGAGCGAGTGTCCAGCCAAGGGCTGAGTGTCCAGCA-CACCTGCCGTCTTCACTTCCCCACTCCGTGGCCGAGCCCTCCACCC-CAGGGCCAGCTTTTCCTCACCAGGAGCCCGGCTTCCACTCCCCACA-TAGGAATAGTCCATCCCCAGATTCGCCATTGTTCACC-3′) is used as template for knockin mutation of miR-615-3p binding site in the hTERT 3′UTR. CRISPR sgRNA used for targeting dCas9-KRAB to HoxC5-binding region are as follows: (1) 5′-GGTGTCAGATTACTAGGGCGGGG-3′; (2) 5′-CCCTAGTAATCTGA-CACCGCAGG-3′; (3) 5′-ACAATGGATCTTACCCACACAGG-3′ and (4) 5′-TGTGCTTAGCTGCTGCCAACAGG-3′.
Western blotting. Cell lysates were electrophoresed on a 10 or 12% SDS-PAGE gel and transferred onto polyvinylidene difluoride membranes, which were then blocked with 5% BSA in TBST [50 mmol/L Tris-HCl (pH 7.4), 150 mmol/l NaCl, and 0.1% Tween 20] for 1 hr, incubated with various primary antibodies overnight and detected with either anti-rabbit or anti-mouse secondary antibodies for 1 hr using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific). The blots were re-probed with anti-actin or anti-GAPDH antibody for protein loading control. Primary antibodies used in the study are: anti-HOXC5 antibody (1:1000, Sigma, #HPA026794), anti-Flag (M2) antibody (1:5000, Sigma-Aldrich, #F1804) and anti-V5 antibody (1:5000, Cell Signaling, #13202). The blots were reprobed with anti-Actin (1:5000, Santa Cruz Biotechnology, #sc1616) or anti-GAPDH antibody (1:1000, Cell Signaling, #2118) for protein loading control. The uncropped western blot scans were shown in Supplementary Fig. 18 .
ChIP-Seq and analysis. Cells were fixed with 1% formaldehyde for 10 min at room temperature, and stopped by adding glycine to a final concentration of 0.2 M. Cells were washed with ice cold TBSE (20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA) for three times. Chromatin were then extracted and sonicated to~500 bp. Input DNA was precleared with protein G Dynabeads (Life technologies), and followed by chromatin immunoprecipitation with Hoxc5 (HPA026794, Sigma) and Pbx4 (HPA049859, Sigma) at 4°C overnight. ChIP beads were washed six times at room temperature. At least 10 ng ChIP DNA were used to prepare libraries with NEBNext ChIP-Seq library prep reagent set (New England Biolabs), and multiplexed (New England Biolabs). Each library was sequenced on Hiseq2000 (Illumina) to an average depth of 20-30 million reads with single-end 101 bp option 65 .
Sequencing reads from ChIP-Seq were mapped against the human reference genome (hg19) using Burrows-Wheeler Aligner (BWA-MEM, version 0.7.0) 66 . High-quality mapped reads (MAPQ ≥10) reads were used for downstream analyses. Reads deemed as PCR duplication were removed using SAMtools. Binding peaks were detected using MACS2 with Q-value ≤ 0.05. Sequencing coverage was computed using MEDIPS 67 with a 50 bp window size and read length extension to 200 bp. DNA-binding motif was detected using MEME with the following parameters: -mod zoops -nmotifs 6 -minw 6 -maxw 50 -revcomp. Particularly, DNA sequences of top 500 binding sites of one transcription factor were used as input.
To investigate the pathways that are associated with endogenous HoxC5 bindings in PC-3, the binding sites were used in GREAT (http://bejerano.stanford.edu/).
Raw sequencing data in the format of.fastq and the processed data generated has been uploaded to GEO. Histone profiles of WA01 and IMR90 were obtained from Broad and REMS/UCSD, respectively through UCSC genome browser 68 . Mapped reads of PC-3 histone profiles (ENCFF537RRY, ENCFF297RXW, ENCFF122EOV, ENCFF945UYG) were downloaded from encodeproject.org.
3C-qPCR materials and methods. 3C-qPCR assays were performed as previously described 69 with slight modifications. Briefly, the assays were performed on PC3 cells overexpressed with HOXC5 or control GFP. 1 × 10 7 nuclei were cross-linked with 1% formaldehyde, digested using DpnII and ligated as described 69 . DNA was then reverse cross-linked and purified by extraction with phenol/chloroform, followed by precipitation with ethanol. The DNA concentration of the 3 C libraries was determined using Picogreen fluorescence assay (Invitrogen). 3C-qPCR reactions were performed by the Sybr-Greener Kit (Invitrogen), and the chromatin interactions were normalized by loading control. On the basis of the 4C-seq data, we selected a region in the hTERT coding region with background levels of interaction, with a similar genomic distance from the hTERT bait region as the experimental interaction, to serve as a control interaction. The primers used for 3c-qPCR are listed in Supplementary Gene expression analysis. The expression data for multiple cancer types were downloaded from TCGA Firehose (http://gdac.broadinstitute.org/runs/ stddata__2016_01_28/data/, Preprocessed Level 3 RSEM log2 normalized). All the relationship of candidate genes was assessed using Spearman's correlation coefficient (r) in samples with non-zero expression. Expression of hTERT was modeled using multiple linear regression (lm()) to determine contribution of individual genes in TGCT and THYM samples. Best linear model was selected using a step wise forward linear regression model. We applied multiple-hypothesis correction by following Benjamini-Hochberg algorithm to calculate false discovery rates (FDRs) based on p values from F statistic of linear regression. The models with FDRs <0.01 were regarded as significant model. All analysis was done in R-3.2.3.
Neural induction of human embryonic stem cells. Neural induction of WA01 and WA18 ES cells was carried out using a previously established protocol 40, 41 . Briefly, ES cells were cultured in mTeSR1 medium. When the ES cell cultures reached~20% confluence, mTeSR1 medium was removed and replaced with neural induction media containing DMEM/F12: Neurobasal (1:1), 1xN2, 1xB27, 1% Glutmax, 5 μg/ml BSA, 4 μM CHIR99021 (Cellagentech), 3 μM SB431542 (Cellagentech), 0.1 μM Compound E (γ-Secretase Inhibitor XXI, EMD Chemicals Inc.), 10 ng/ml hLIF (Millipore) for 7 days. The culture was then split 1:3 for the next six passages using Accutase, and the cells were cultured in human neural progenitor cells (NPCs) maintenance media containing DMEM/F12: Neurobasal (1:1), 1xN2, 1xB27, 1% Glutmax, 5 μg/ml BSA, 3 μM CHIR99021, 2 μM SB431542, 10 ng/ml hLIF on matrigel-coated plates. After six passages, the cells were split 1:10 regularly.
Immunocytochemistry. For immunofluorescence assays, we have adapted the procedure from previous publications 70 . Briefly, the cells were fixed with 3.7% formaldehyde (vol/vol) in 1× tris-buffered saline (TBS) for 10 min at room temperature. Cells were blocked in permeabilization and blocking buffer (2% normal goat serum, 0.4% trixton X-100, 1 × TBS) for 60 min at room temperature and then incubated with primary antibody, mouse anti-TRF2 (1:50, Merck, #630787) and rabbit anti-γ-H2AX (1:1000, Cell Signaling Technologies, #9718) for 16 hr at 4 degree. The following day, cells were washed with wash buffer (0.4% triton X-100 in 1 × TBS) and incubated with secondary antibody, goat anti-mouse IgG alexa fluor 488 (1:1000, Invitrogen, #A11029) and goat anti-rabbit IgG alexa fluor 568 (1:1000, Invitrogen, #A11036) respectively for 60 min at room temperature. Nuclei were visualized by DAPI staining (Sigma-Aldrich). Images were acquired on IX83 Olympus fluorescence microscope. Images were analyzed using ImageJ software.
Colony formation assay. For colony formation assay, 300 cells per condition were plated in triplicates and cultured for two weeks before staining for viable colonies with crystal violet dye.
Tumor xenograft in NSG mice. PC-3 cells were suspended in 1× Matrigel at a concentration of 2 × 10 6 cells per 100 μl, and the cells were injected subcutaneously into 4-to 6-week-old NSG mice (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ) in the dorsolateral area bilaterally. Tumor volume and body weight were measured every week. Tumor volume was calculated using the formula, S 2 xL/2, where S and L represent the small and large diameters of the tumor, respectively. All animal studies were conducted in compliance with animal protocols approved by Institutional Animal Care and Use Committee (IACUC) of Singapore.
Statistical analysis. Each assay was repeated in three independent experiments. Statistical significance of differences between groups was analyzed using Student's t test or ANOVA analysis. P < 0.05 was considered significant. All the data obtained are presented as mean ± SEM. The relationship of candidate genes was assessed using Spearman's correlation coefficient (r). If the P value is lower than 5% (P < 0.05), the correlation coefficient is deemed to be statistically significant.
Data availability. ChIP-Seq data are available at Gene Expression Omnibus (GSE97570).
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